These Are The Top 5 USA Stocks In 2026 With The Highest Returns, according to year-to-date market performance through November 6, 2026. From biotechnology and semiconductor technology to energy companies, these market leaders have delivered impressive gains, attracting attention from investors looking for the year's strongest-performing stocks.
The US stock market has experienced significant differences in performance across industries during 2026. While some companies have benefited from strong demand and business developments, others have experienced substantial share-price movements driven by company-specific events.
Based on a November 6, 2026, large-cap stock performance screen covering companies with market capitalizations between $10 billion and $200 billion, the following five US companies are among the strongest performers.
The figures represent year-to-date share-price returns, not guaranteed future gains. <Link url="https://www.quantisnow.com/rankings/ytd-gainers/large-cap" title="View the 2026 large-cap stock performance rankings"/>.
Moderna is one of the most remarkable stock-market performers of 2026. The biotechnology company has recorded an approximately 762% year-to-date gain through November 6, according to the large-cap performance screen.
The company is widely known for developing mRNA-based medicines and vaccines. Its technology platform has attracted attention across infectious diseases, oncology, and other areas of medical research.
Moderna's business outlook depends on factors such as product development, clinical trial results, regulatory decisions, commercial sales, and its ability to bring new treatments to market.
The significant share-price increase makes Moderna an important company to watch, but biotechnology stocks can be especially volatile. Clinical setbacks, regulatory delays, and changes in revenue expectations can quickly affect investor sentiment.
Investors interested in understanding the company's business should review its financial reports and research updates before evaluating the stock.
Official website: <Link url="https://www.modernatx.com/" title="Moderna – Company and Research Information"/>.
SanDisk ranks among the strongest-performing large-cap stocks in the 2026 performance screen, with an approximately 251.8% year-to-date gain.
The company operates in the data-storage industry, developing flash-memory and storage products used in consumer electronics, computing, enterprise systems, and other technology applications.
Demand for data storage is an important consideration as artificial intelligence, cloud computing, and digital services continue to generate large volumes of information.
SanDisk's performance has attracted investor attention as the storage industry remains an important part of the broader technology ecosystem.
However, the memory and storage business can experience changing supply-and-demand conditions, pricing pressure, competition, and shifts in technology requirements. Strong historical returns do not automatically mean that the stock will continue rising.
Investors should examine revenue growth, margins, product demand, and future business guidance.
Official website: <Link url="https://www.sandisk.com/" title="SanDisk – Official Website"/>.
Revolution Medicines is another notable performer in 2026, delivering an approximately 141.4% year-to-date share-price increase.
The biotechnology company focuses on developing targeted treatments for cancers driven by RAS-related pathways. Its research programs have attracted attention because of the importance of RAS signaling in several types of cancer.
Clinical development is a major factor for companies in this sector. Positive trial results, new research developments, regulatory milestones, and potential partnerships can influence investor expectations.
However, biotechnology investments carry substantial risks. A promising drug candidate may still face clinical challenges, regulatory requirements, or commercial uncertainty.
Investors considering Revolution Medicines should review its clinical pipeline, financial position, research updates, and SEC filings rather than relying only on its recent stock performance.
Official website: <Link url="https://www.revmed.com/" title="Revolution Medicines – Company and Pipeline Information"/>.
Marathon Petroleum has also delivered a strong performance in 2026, recording an approximately 129.2% year-to-date return in the large-cap ranking.
The company is one of the major independent petroleum refining, marketing, and transportation businesses in the United States.
Its operations include refining crude oil into transportation fuels and other petroleum products, along with marketing and logistics activities.
Energy-company share prices can respond to several market factors, including refining margins, crude oil prices, fuel demand, operating costs, and global economic conditions.
Marathon Petroleum's performance makes it an interesting company for investors researching the energy sector. However, its future results will depend on industry conditions, operational efficiency, capital spending, and market demand.
Investors should also examine the company's debt, cash flow, dividends, and financial guidance when assessing its longer-term prospects.
Official website: <Link url="https://www.marathonpetroleum.com/" title="Marathon Petroleum – Investor and Company Information"/>.
Valero Energy completes this list with an approximately 112.8% year-to-date share-price increase through November 6, 2026.
Valero is a major independent refiner and producer of renewable fuels. Its operations include petroleum refining, renewable diesel production, and ethanol manufacturing.
The company's financial performance can be influenced by refining margins, fuel consumption, crude oil supply, transportation demand, and renewable fuel market conditions.
Investors following the energy industry may find Valero worth researching because it provides exposure to several areas of the fuel and energy supply chain.
Nevertheless, energy stocks can experience sharp movements when commodity prices, refining conditions, or economic expectations change. Investors should evaluate the company's latest earnings reports and financial outlook before making investment decisions.
Official website: <Link url="https://www.valero.com/" title="Valero Energy – Official Website"/>.
Here is a quick comparison of the five companies and their reported year-to-date returns through November 6, 2026.
| Company | Ticker | Approx. YTD return |
|---|---|---|
| Moderna | MRNA | +762.0% |
| SanDisk | SNDK | +251.8% |
| Revolution Medicines | RVMD | +141.4% |
| Marathon Petroleum | MPC | +129.2% |
| Valero Energy | VLO | +112.8% |
Source: Quantisnow large-cap performance ranking, November 6, 2026. Returns are approximate, split-adjusted share-price changes and exclude dividends. The screen covers companies with market capitalizations between $10 billion and $200 billion.
The five companies operate in different industries, demonstrating that strong stock-market performance is not limited to one particular sector.
Several themes are worth understanding:
Biotechnology developments: Clinical research, drug development, and potential medical breakthroughs can influence biotechnology valuations.
Artificial intelligence and data storage: Growing computing requirements have increased attention on the companies supplying essential storage technology.
Energy market conditions: Refining margins, fuel demand, and operating performance can influence petroleum companies.
Company-specific developments: Earnings announcements, financial guidance, business announcements, and regulatory updates can create significant share-price movements.
Investors should research the business developments behind each stock's performance rather than assuming that a rising share price automatically indicates stronger long-term fundamentals.
The stocks with the highest returns are not necessarily the best investments for every individual. A company that has already experienced a major price increase may carry significant valuation and volatility risks.
Before considering any of these stocks, investors should examine:
Recent revenue and earnings growth.
Company debt and cash-flow position.
Valuation compared with industry competitors.
Future business guidance and potential risks.
Competitive advantages and market opportunities.
Whether the investment matches their financial goals and risk tolerance.
Diversification is also important. Concentrating an entire portfolio in a few high-performing companies can expose investors to substantial losses if market conditions change.
For additional research, investors can consult SEC company filings, Nasdaq market information, and Investor.gov.
The 2026 stock market has produced some extraordinary performers, with Moderna, SanDisk, Revolution Medicines, Marathon Petroleum, and Valero Energy standing out in the selected large-cap performance screen.
Their gains reflect different industries, business developments, and market conditions. However, year-to-date returns only describe what has already happened. Investors should evaluate company fundamentals, current valuations, and potential risks before making investment decisions.
The strongest-performing stock of 2026 may not necessarily be the strongest investment for the next year. Careful research and a diversified investment strategy remain important when navigating the US stock market.